Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Testosterone may slow down wound healing and increase inflammation.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Early onset hair loss linked to genetics and androgen levels.

Mutations in certain receptors can cause diseases and offer new treatment options.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Androgens affect the function and health of the endometrium.

AR gene variations don't affect aging markers in men.

Gene variation affects prostate issues and hair loss.

Excess androgens may cause PCOS, not just be a symptom.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgens can both increase and decrease hair growth in different parts of the body.

Finasteride safely lowers DHT levels without affecting testosterone.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.